Clinical Trials Logo

Esophageal Stricture clinical trials

View clinical trials related to Esophageal Stricture.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05581173 Recruiting - Clinical trials for Esophageal Stricture

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

Start date: September 19, 2022
Phase:
Study type: Observational [Patient Registry]

The study is designed as a multicenter prospective registry study evaluating the efficacy of the self-assembling peptide in the prevention of stricture formation after endoscopic resection as part of standard medical care. No experimental interventions will be performed.

NCT ID: NCT05561114 Recruiting - Clinical trials for Esophageal Stricture

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

PATENT-E
Start date: December 1, 2023
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of the ProTractX3™ DCB for the treatment of benign esophageal strictures.

NCT ID: NCT04406428 Recruiting - Clinical trials for Esophageal Stricture

NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures

SAMURAI
Start date: September 14, 2020
Phase: N/A
Study type: Interventional

Rationale: The study hypothesizes that NKI followed by endoscopic bougie dilation therapy will result in an increased dysphagia-free period, a reduction of endoscopic procedures and dysphagia-related quality of life, and lower costs, when compared with the standard endoscopic bougie dilation (EBD) in recurrent esophagogastric anastomotic strictures. Objective: To evaluate the efficacy and cost-effectiveness of needle-knife incision (NKI) followed by EBD compared to standard EBD in patients with recurrent esophagogastric anastomotic strictures. Study design: This multicenter study is an randomized controlled trial in which NKI followed by EBD will be compared with standard EBD. Study population: Patients with recurrent dysphagia (at least 1 and a maximum of 5 previous dilations) due to an anastomotic esophagogastric stricture that requires treatment with repeated endoscopic bougie dilations. Intervention : The intervention to be investigated is the addition of NKI therapy to EBD to 18 mm esophageal diameter. Main study parameters/endpoints: The primary outcome of this study will be EBD-free time during follow-up of 6 months. Secondary outcome parameters will be the number of endoscopic procedures for treatment of dysphagia, quality of life (QoL), cost-reduction and cost-effectiveness.

NCT ID: NCT00551824 Recruiting - Clinical trials for Esophageal Stricture

Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children

Start date: October 2007
Phase: N/A
Study type: Interventional

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures. This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.